Brazil Diagnostic Imaging Services market Report 2022 to 2030

Brazil Diagnostic Imaging Services market Analysis

$ 3999

The Brazil Diagnostic Imaging Services market size was valued at $13.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9 % from 2022 to 2030 and will reach $20.76 Bn in 2030. The market is segmented by product, application, and end user. The Brazil Diagnostic Imaging Services market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Grupo Fleury (BRA), DASA (BRA), Alliar (BRA), Diagnósticos da América (DASA) (BRA), Clínica Imagem (BRA)

ID: IN10BRHS054 CATEGORY: Healthcare Services GEOGRAPHY: Brazil AUTHOR: Chandani Patel

Buy Now

Brazil Diagnostic Imaging Services Market Executive Summary

The Brazil Diagnostic Imaging Services market size was valued at $13.12 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9 % from 2022 to 2030 and will reach $20.76 Bn in 2030. Diagnostic imaging is a phrase used to describe the use of various imaging technologies in India to identify and treat medical conditions. Some examples of these technologies are X-rays, CT scans, MRIs, ultrasounds, and nuclear medicine scans. Diagnostic imaging services in India are mostly provided by hospitals, clinics, and private imaging centres. While these therapies are typically publicly subsidised and provided through the country's universal healthcare system, there are private options available for people who would rather pay out of pocket.

To guarantee patient safety and the validity of test results, diagnostic imaging use is strictly controlled in Brazil. Radiologic technicians must be certified by the Canadian Association of Medical Radiation Technologists in order to operate imaging equipment. The length of time a patient must wait for diagnostic imaging services in Brazil might change depending on the test and how critical their condition is. A patient may occasionally have to wait a lengthy period because of a strong demand for treatments or a lack of available resources.

So, there is a huge opportunity for medical equipment manufacturers to grow in Brazil. The need for medical equipment grows as the frequency of chronic diseases does as well.

brazil diagnostic imaging market

Market Dynamics

Market Growth Drivers

The Brazilian government has made significant investments in the infrastructure of the healthcare system and is supporting the expansion of the healthcare industry, which includes diagnostic imaging. Moreover, advancements in diagnostic imaging technologies, such as 3D printing, artificial intelligence, and precision medicine, are driving innovation and market expansion. Increasing the number of people with access to health insurance has also increased the number of medical professionals who can offer coverage to patients.

Market Restraints

Diagnostic imaging services are frequently inaccessible, especially in distant places, due to the cost of diagnostic imaging equipment like MRI machines and CT scanners. In addition, radiologists and technicians, who are educated to handle and interpret diagnostic imaging equipment, are in short supply.

However, individuals may choose less expensive options like traditional Brazilian medicine, which might impede the expansion of the diagnostic imaging sector. The regulatory climate in Brazil may be challenging, particularly for foreign companies wanting to enter the market, which can stifle innovation and growth.

Competitive Landscape

Key Players
Grupo Fleury (BRA)
DASA (BRA)
Alliar (BRA)
Diagnósticos da América (DASA) (BRA)
Clínica Imagem (BRA)
Rede Brasileira de Diagnóstico (RBD) (BRA)
CDB Medicina Diagnóstica (BRA)
Salomão Zoppi (BRA)
Sabin Medicina Diagnóstica (BRA)
Alta Excelência Diagnóstica (BRA)

Recent Developments

March 2021: A division of Alliar named Alliar Médicos a Frente purchased the Brazilian organisation Instituto de Radiologia de Maringá (IRM). Alliar will be able to boost its operations and market share in the nation thanks to this purchase.

September 2020: The Fleury Genômica, a new platform created by Grupo Fleury, provides patients with services for genomic sequencing and genetic testing. With the use of this new platform, Fleury will be able to increase the range of diagnostic services it provides and give patients more specialised treatment choices.

Healthcare Policies and Regulatory Landscape

In Brazil, diagnostic imaging is regulated by the National Health Surveillance Agency (ANVISA) and the Federal Council of Medicine (CFM). The CFM develops ethical and technical standards for the medical profession, including the use of diagnostic imaging, while the ANVISA is in charge of regulating the use of medical equipment.

Any diagnostic imaging equipment used in Brazil must comply with ANVISA's certification and registration requirements. To guarantee patient safety, they also develop rules for the setup, use, and upkeep of equipment. The CFM controls how radiologists and other specialists who work in the medical field use diagnostic imaging. They provide forth standards for the proper use of imaging, including when it is required and what kind of imaging is best in a particular circumstance. They also provide guidelines for how imaging data should be interpreted and how patients and other healthcare professionals should be informed of the results.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Segmentation

Diagnostic Imaging Services Market Segmentation

By Producta

Six product categories make up the market: mammography systems, CT scanners, ultrasound, MRI, and X-ray machines. The technology expected to expand the fastest during the projected period is CT scanners. Their broad application in hospitals and imaging centres for cancer and pulmonary screening, the expansion of their application horizon to include dentistry and interventional procedures, the availability of reimbursements in developed countries, and the ongoing digitalization of healthcare systems all contribute to their significant growth potential.

X-ray Imaging Systems
By Technology
- X-ray Digital Imaging Systems
  - Direct Radiography (DR)
  - Computed Radiography (CR)
- X-ray Analog Imaging Systems
By Portability
Stationary Systems
Portable Systems
Computed Tomography (CT) Scanners
Conventional CT systems
Cone Beam CT Systems (CBCT)
High-slice CT Scanners
Mid-slice CT Scanners
Low-slice CT Scanners
By Technology
2D Ultrasound
3D and 4D Ultrasound
Doppler Ultrasound
Trolley/Cart-based Ultrasound Systems
Compact/Portable Ultrasound Systems
Conventional CT Systems Market, by Technology
Closed MRI
Open MRI
High- and Very-high-field MRI Systems
Low-to-mid-field MRI Systems
Ultra-high-field MRI Systems
Ultrasound Systems
Standalone SPECT Systems
Hybrid SPECT Systems
By Technology
By Portability
Magnetic Resonance Imaging (MRI) Systems
By Architecture
By Field Strength
Nuclear Imaging Systems
SPECT Systems
Hybrid PET Systems
Mammography Systems

By Application

The market is divided into several modalities, such as mammography systems, MRI systems, ultrasound systems, X-ray imaging systems, CT scanners, and nuclear imaging systems, based on the applications they are used for. Cardiology under CT scanners, brain and neurological MRI under MRI systems, radiology and general imaging under ultrasound systems, general radiography applications under X-ray imaging systems, and cancer under nuclear imaging systems made up the majority of the applications in 2021. Among all application categories of the diagnostic imaging market in 2021, general radiography applications under the X-ray imaging systems application represented the greatest market share.

X-ray Imaging Systems
- General Radiography
- Dental
- Fluoroscopy
MRI Systems
Brain & Neurological MRI
Spine & Musculoskeletal MRI
Vascular MRI
Pelvic & Abdominal MRI
Breast MRI
Cardiac MRI
Radiology/General Imaging
Cardiology
Obstetrics/Gynecology
Urology
Vascular
Other Applications
Cardiology
Oncology
Neurology
Other Applications
Cardiology
Oncology
Neurology
Other Applications
Ultrasound Systems
CT Scanners
Nuclear Imaging Systems
Mammography Systems

By End User

The various end-user segments of the worldwide diagnostic imaging services market include hospitals, ambulatory surgical centres, diagnostic centres, and others. Hospitals are the main consumers of diagnostic imaging services, making them a critical market for service providers. Hospitals see a large influx of patients because they offer a wide variety of diagnostic imaging technology for patients. Due to the rise in the recommendation of diagnostic imaging tests for speedy and precise detection of patient medical conditions, the hospitals sector held the highest share of the market in 2022.

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.